Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and central nervous system (CNS) agents. Its structure supports the formation of bioactive molecules due to the presence of a protected amine and a hydroxyl group, enabling selective modifications in drug design. Commonly employed in medicinal chemistry for constructing constrained azetidine scaffolds, which improve metabolic stability and binding affinity in target molecules. Also utilized in the preparation of protease inhibitors and receptor modulators where ring strain and polarity influence pharmacokinetic properties.